Stryker has secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis. The ...

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe ...